title: An allogeneic NK cell line engineered to express chimeric antigen receptors: A novel strategy of cellular immunotherapy against cancer.
authors.affiliation: INSERM U970, Universite Paris Descartes, Sorbonne Paris-Cité; Paris, France ; Hôpital Européen Georges Pompidou; AP-HP; Service d'Anatomie Pathologique; Paris, France.
authors.forename: Cécile
authors.initials: C
authors.lastname: Badoual
authors.affiliation: INSERM U970, Universite Paris Descartes, Sorbonne Paris-Cité; Paris, France.
authors.forename: Pierre-Louis
authors.initials: PL
authors.lastname: Bastier
authors.affiliation: INSERM U970, Universite Paris Descartes, Sorbonne Paris-Cité; Paris, France ; Hôpital Européen Georges Pompidou; AP-HP; Service d'Anatomie Pathologique; Paris, France.
authors.forename: Hélène
authors.initials: H
authors.lastname: Roussel
authors.affiliation: INSERM U970, Universite Paris Descartes, Sorbonne Paris-Cité; Paris, France.
authors.forename: Marion
authors.initials: M
authors.lastname: Mandavit
authors.affiliation: Hôpital Européen Georges Pompidou; AP-HP; Service d'Immunologie Biologique; Paris, France.
authors.forename: Eric
authors.initials: E
authors.lastname: Tartour
references.citation: Blood. 2013 Dec 12;122(25):4129-39
references.pmid: 24055823
references.citation: N Engl J Med. 2011 Aug 25;365(8):725-33
references.pmid: 21830940
references.citation: Cytotherapy. 2008;10(6):625-32
references.pmid: 18836917
references.citation: Eur J Immunol. 2013 Feb;43(2):331-4
references.pmid: 23322344
references.citation: Cancer Gene Ther. 2012 Feb;19(2):84-100
references.pmid: 21979579
references.citation: Oncoimmunology. 2013 May 1;2(5):e24238
references.pmid: 23762803
references.citation: Cancer Res. 2013 Jun 15;73(12):3499-510
references.pmid: 23592754
references.citation: Biomed Pharmacother. 1992;46(10):473-84
references.pmid: 1306361
references.citation: N Engl J Med. 2013 Apr 18;368(16):1509-1518
references.pmid: 23527958
references.citation: Oncoimmunology. 2013 Oct 1;2(10):e26527
references.pmid: 24404423
references.citation: J Immunother. 2007 Oct;30(7):684-93
references.pmid: 17893561
references.citation: PLoS One. 2013;8(2):e56820
references.pmid: 23441216
references.citation: Science. 2011 Jan 7;331(6013):44-9
references.pmid: 21212348
references.citation: Oncoimmunology. 2012 May 1;1(3):306-315
references.pmid: 22737606
references.citation: Mol Ther. 2009 Aug;17(8):1453-64
references.pmid: 19384291
references.citation: Sci Transl Med. 2013 Mar 20;5(177):177ra38
references.pmid: 23515080
references.citation: Curr Opin Immunol. 2009 Oct;21(5):525-30
references.pmid: 19717293
references.citation: Gene Ther. 2013 Nov;20(11):1029-32
references.pmid: 23804078
references.citation: Crit Rev Immunol. 2009;29(2):87-109
references.pmid: 19496742
references.citation: Sci Transl Med. 2013 Feb 13;5(172):172ra20
references.pmid: 23408053